Nurse Practitioner, Gerontology · East Orange, NJ
NPI
1932644812
Since 2016
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
7
Medicare group memberships
Hospitals
1
Hospital affiliations
613 Park Ave, 2nd Floor
East Orange, NJ, 07017
Phone (973) 672-2455
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,642
184 services
Medicare patients, 2024
37
Average age 68
Drug cost, 2024
$2.3M
8,944 prescriptions
Company payments, 2025
$1,780
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Christina Errazo was code 99214 (office e&m - established), 32 times for 20 patients. In total Maria Christina Errazo billed 184 services in 32 codes, and Medicare paid $9,642.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 32 | 20 | $91.74 | $2,936 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 13 | $11.07 | $166 |
By year: 2022 $16K for 297 services; 2023 $7,003 for 119 services; 2024 $9,642 for 184 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Christina Errazo prescribed most often to Medicare patients was Atorvastatin Calcium, with 497 prescriptions and refills. In total Maria Christina Errazo wrote 8,944 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 497 | 1,156 | 179 | $5,063 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 274 | 314 | 78 | $6,360 |
| Ozempic Semaglutide | 263 | 353 | 63 | $327K |
| Amlodipine Besylate Generic | 248 | 523 | 89 | $1,301 |
| Rosuvastatin Calcium Generic | 231 | 527 | 84 | $2,772 |
| Levocarnitine Generic | 223 | 299 | 56 | $16K |
| Gabapentin Generic | 215 | 294 | 68 | $2,198 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 209 | 288 | 59 | $184K |
| Repatha Sureclick Evolocumab | 196 | 225 | 46 | $126K |
| Jardiance Empagliflozin | 180 | 260 | 46 | $153K |
| Ezetimibe Generic | 172 | 291 | 61 | $2,678 |
| Omeprazole Generic | 150 | 296 | 54 | $2,169 |
| Farxiga Dapagliflozin Propanediol | 148 | 202 | 36 | $111K |
| Eliquis Apixaban | 142 | 216 | 39 | $122K |
| Kerendia Finerenone | 141 | 186 | 34 | $116K |
Brand drugs: 2,456 claims; generic drugs: 6,337 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Christina Errazo $1,780 ($1,780 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novo Nordisk Inc with $334.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 25 | $334 |
| Lilly USA, LLC LLY | 13 | $227 |
| Amgen Inc. AMGN | 11 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $165 |
| Abbvie Inc. ABBV | 12 | $160 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $144 |
| Pfizer Inc. PFE | 7 | $113 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $101 |
| GlaxoSmithKline, LLC. GSK | 5 | $94.76 |
| Insulet Corporation PODD | 3 | $61.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.